

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.30365811 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.30365811 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.29386417 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.22301577 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.22301577 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.19786313 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.19786313 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 6.19786313 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 6.19786313 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 6.19786313 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.19786313 |
| 12 | negative regulation of cell killing (GO:0031342) | 6.10766854 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.10766854 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.78094677 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.54737318 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.48274210 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 5.46283088 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.37606735 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 5.29565987 |
| 20 | lysine catabolic process (GO:0006554) | 5.26210661 |
| 21 | lysine metabolic process (GO:0006553) | 5.26210661 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.18388585 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.10245854 |
| 24 | detection of other organism (GO:0098543) | 5.09758524 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08183433 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.05425959 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 5.03192319 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.99484401 |
| 29 | kynurenine metabolic process (GO:0070189) | 4.96182043 |
| 30 | cysteine metabolic process (GO:0006534) | 4.95079277 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 4.89189010 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 4.89189010 |
| 33 | tryptophan catabolic process (GO:0006569) | 4.89189010 |
| 34 | response to peptidoglycan (GO:0032494) | 4.78322721 |
| 35 | detection of external biotic stimulus (GO:0098581) | 4.77366164 |
| 36 | cellular extravasation (GO:0045123) | 4.76015644 |
| 37 | bile acid biosynthetic process (GO:0006699) | 4.75241595 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74419268 |
| 39 | detection of bacterium (GO:0016045) | 4.68159126 |
| 40 | tryptophan metabolic process (GO:0006568) | 4.59812908 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.57510724 |
| 42 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52118888 |
| 43 | microglial cell activation (GO:0001774) | 4.49990846 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.44056339 |
| 45 | urea metabolic process (GO:0019627) | 4.43041779 |
| 46 | urea cycle (GO:0000050) | 4.43041779 |
| 47 | neutrophil activation (GO:0042119) | 4.42756854 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.39093843 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 4.38632757 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.38306717 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 4.37697481 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.37280617 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 4.34801592 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 4.33709192 |
| 55 | protein carboxylation (GO:0018214) | 4.33597243 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.33597243 |
| 57 | regulation of triglyceride catabolic process (GO:0010896) | 4.30985926 |
| 58 | fatty acid beta-oxidation (GO:0006635) | 4.28252691 |
| 59 | response to interleukin-15 (GO:0070672) | 4.25141460 |
| 60 | homocysteine metabolic process (GO:0050667) | 4.24140649 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21010140 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17066994 |
| 63 | response to host immune response (GO:0052572) | 4.17066994 |
| 64 | detection of biotic stimulus (GO:0009595) | 4.17048991 |
| 65 | complement activation, alternative pathway (GO:0006957) | 4.15667002 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 4.14537347 |
| 67 | ethanol oxidation (GO:0006069) | 4.14081205 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 4.13896934 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12704198 |
| 70 | aspartate family amino acid catabolic process (GO:0009068) | 4.12386222 |
| 71 | 2-oxoglutarate metabolic process (GO:0006103) | 4.09796675 |
| 72 | bile acid metabolic process (GO:0008206) | 4.09753888 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 4.08540072 |
| 74 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.08432124 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 4.07664378 |
| 76 | aromatic amino acid family metabolic process (GO:0009072) | 4.05692310 |
| 77 | fatty acid oxidation (GO:0019395) | 4.05162703 |
| 78 | macrophage activation (GO:0042116) | 4.03789677 |
| 79 | regulation of protein activation cascade (GO:2000257) | 4.03572689 |
| 80 | respiratory burst (GO:0045730) | 4.02710534 |
| 81 | neutrophil mediated immunity (GO:0002446) | 4.02668292 |
| 82 | regulation of fibrinolysis (GO:0051917) | 4.01224032 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 4.01100229 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.98154110 |
| 85 | lipid oxidation (GO:0034440) | 3.97678697 |
| 86 | leukocyte aggregation (GO:0070486) | 3.96860948 |
| 87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.96685403 |
| 88 | granulocyte activation (GO:0036230) | 3.96466624 |
| 89 | reverse cholesterol transport (GO:0043691) | 3.94496128 |
| 90 | glutamate metabolic process (GO:0006536) | 3.93498412 |
| 91 | acylglycerol homeostasis (GO:0055090) | 3.92957372 |
| 92 | triglyceride homeostasis (GO:0070328) | 3.92957372 |
| 93 | fatty acid catabolic process (GO:0009062) | 3.90788630 |
| 94 | valine metabolic process (GO:0006573) | 3.90673643 |
| 95 | coenzyme catabolic process (GO:0009109) | 3.90163647 |
| 96 | regulation of mast cell degranulation (GO:0043304) | 3.85272381 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 3.85088525 |
| 98 | carnitine metabolic process (GO:0009437) | 3.84693182 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83315616 |
| 100 | response to host (GO:0075136) | 3.83315616 |
| 101 | response to host defenses (GO:0052200) | 3.83315616 |
| 102 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83121330 |
| 103 | protein-lipid complex remodeling (GO:0034368) | 3.83121330 |
| 104 | macromolecular complex remodeling (GO:0034367) | 3.83121330 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.83107324 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82876994 |
| 107 | regulation of cholesterol esterification (GO:0010872) | 3.82788214 |
| 108 | cellular response to interleukin-15 (GO:0071350) | 3.81084401 |
| 109 | tyrosine metabolic process (GO:0006570) | 3.80958003 |
| 110 | regulation of complement activation (GO:0030449) | 3.80297778 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 3.79473978 |
| 112 | ketone body metabolic process (GO:1902224) | 3.79023291 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.74771168 |
| 114 | plasma lipoprotein particle clearance (GO:0034381) | 3.74346826 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 3.74064926 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 3.73510956 |
| 117 | organic acid catabolic process (GO:0016054) | 3.71302556 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 3.71302556 |
| 119 | negative regulation of cholesterol transport (GO:0032375) | 3.70796099 |
| 120 | negative regulation of sterol transport (GO:0032372) | 3.70796099 |
| 121 | positive regulation of mast cell activation (GO:0033005) | 3.70473357 |
| 122 | cellular glucuronidation (GO:0052695) | 3.68037820 |
| 123 | drug catabolic process (GO:0042737) | 3.67925311 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 3.66823846 |
| 125 | drug transmembrane transport (GO:0006855) | 3.66561949 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.65333202 |
| 127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.63676161 |
| 128 | fatty acid transmembrane transport (GO:1902001) | 3.62555076 |
| 129 | positive regulation of fatty acid oxidation (GO:0046321) | 3.61651422 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.60889505 |
| 131 | phospholipid efflux (GO:0033700) | 3.59758256 |
| 132 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59628311 |
| 133 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.58969281 |
| 134 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55344030 |
| 135 | glycine metabolic process (GO:0006544) | 3.54847221 |
| 136 | regulation of cholesterol homeostasis (GO:2000188) | 3.54816301 |
| 137 | branched-chain amino acid metabolic process (GO:0009081) | 3.53833848 |
| 138 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51903954 |
| 139 | indolalkylamine metabolic process (GO:0006586) | 3.49241853 |
| 140 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.48951511 |
| 141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47459926 |
| 142 | regulation of mast cell activation (GO:0033003) | 3.46555391 |
| 143 | serine family amino acid biosynthetic process (GO:0009070) | 3.44808179 |
| 144 | bile acid and bile salt transport (GO:0015721) | 3.43740477 |
| 145 | benzene-containing compound metabolic process (GO:0042537) | 3.42321013 |
| 146 | flavonoid metabolic process (GO:0009812) | 3.41831768 |
| 147 | carnitine shuttle (GO:0006853) | 3.41542502 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 3.36630620 |
| 149 | phospholipid homeostasis (GO:0055091) | 3.35600752 |
| 150 | epoxygenase P450 pathway (GO:0019373) | 3.35526120 |
| 151 | urate metabolic process (GO:0046415) | 3.33979419 |
| 152 | myeloid leukocyte mediated immunity (GO:0002444) | 3.32855378 |
| 153 | cholesterol efflux (GO:0033344) | 3.32426888 |
| 154 | regulation of cholesterol metabolic process (GO:0090181) | 3.31489424 |
| 155 | regulation of leukocyte degranulation (GO:0043300) | 3.30791974 |
| 156 | arginine metabolic process (GO:0006525) | 3.30551386 |
| 157 | biotin metabolic process (GO:0006768) | 3.28384422 |
| 158 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.26844374 |
| 159 | regulation of fatty acid oxidation (GO:0046320) | 3.26080082 |
| 160 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.25244001 |
| 161 | cholesterol homeostasis (GO:0042632) | 3.24273098 |
| 162 | dendritic cell migration (GO:0036336) | 3.23312137 |
| 163 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23089504 |
| 164 | sterol homeostasis (GO:0055092) | 3.22499227 |
| 165 | regulation of tolerance induction (GO:0002643) | 3.21226822 |
| 166 | positive regulation of mast cell degranulation (GO:0043306) | 3.18893315 |
| 167 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.18893315 |
| 168 | regulation of T cell tolerance induction (GO:0002664) | 3.17908967 |
| 169 | leukocyte degranulation (GO:0043299) | 3.15216286 |
| 170 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.15103725 |
| 171 | regulation of B cell differentiation (GO:0045577) | 3.14181768 |
| 172 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.12851788 |
| 173 | B cell mediated immunity (GO:0019724) | 3.10008971 |
| 174 | positive regulation of B cell differentiation (GO:0045579) | 3.08399617 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.06689942 |
| 176 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.06689942 |
| 177 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06197547 |
| 178 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06051452 |
| 179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05159639 |
| 180 | dendritic cell chemotaxis (GO:0002407) | 3.03898348 |
| 181 | cellular response to type I interferon (GO:0071357) | 3.02771943 |
| 182 | type I interferon signaling pathway (GO:0060337) | 3.02771943 |
| 183 | response to type I interferon (GO:0034340) | 3.00477938 |
| 184 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98842246 |
| 185 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.98739598 |
| 186 | defense response to protozoan (GO:0042832) | 2.98407491 |
| 187 | myeloid leukocyte activation (GO:0002274) | 2.96244817 |
| 188 | positive regulation of interferon-alpha production (GO:0032727) | 2.94767427 |
| 189 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92931982 |
| 190 | regulation of regulated secretory pathway (GO:1903305) | 2.92388938 |
| 191 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92197790 |
| 192 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91959698 |
| 193 | negative thymic T cell selection (GO:0045060) | 2.91203623 |
| 194 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.86236641 |
| 195 | response to muramyl dipeptide (GO:0032495) | 2.85887574 |
| 196 | negative regulation of phagocytosis (GO:0050765) | 2.85393122 |
| 197 | negative T cell selection (GO:0043383) | 2.84501821 |
| 198 | negative regulation of type 2 immune response (GO:0002829) | 2.83584110 |
| 199 | germinal center formation (GO:0002467) | 2.82805520 |
| 200 | negative regulation of interleukin-6 production (GO:0032715) | 2.80804432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.23491548 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.68859476 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.25178770 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.66840754 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.61173061 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.91074782 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.89452271 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47114669 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.38840626 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84969521 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.80942333 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78542931 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.75952150 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.68594670 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40343631 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.38688783 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.32385203 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02103098 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95574679 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89744889 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.88267977 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76650070 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73079315 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.71411153 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67766696 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46048798 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.42859654 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41057966 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38281379 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36203103 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.30137227 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17621500 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16292723 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14124023 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13504969 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08144322 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08109660 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 2.06947406 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02429856 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01711465 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1355668 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95956670 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.95455241 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91004089 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.90609513 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84619595 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82603522 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82047111 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80896347 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78108278 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75955306 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73134085 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.68828311 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65382314 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64595813 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63101006 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61697625 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59833321 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50107298 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48055614 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46032644 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45262170 |
| 63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44633199 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44522519 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43543255 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43115753 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41612873 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41292749 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40403814 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.40050175 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39776745 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.39338117 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38966113 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38010100 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36134077 |
| 76 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36064193 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35966785 |
| 78 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34425042 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32707257 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30793908 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30376599 |
| 82 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29277487 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27782668 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27426653 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26847564 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26497818 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24894646 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21307610 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19538058 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17449903 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15626533 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13914156 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13055229 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08848555 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08045755 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07264822 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06773825 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06524923 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06494608 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05122403 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05122403 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04826104 |
| 103 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04546108 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04156820 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03940543 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03821791 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03821791 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02725710 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98799860 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98626911 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96995025 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96488468 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96330702 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96130345 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94613325 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94230897 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91539116 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91255548 |
| 119 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90536259 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89473648 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88509909 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87648726 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87569799 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87511732 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86302866 |
| 126 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85715992 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85302909 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83048659 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82925590 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82408567 |
| 131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82261411 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81794489 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80958970 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78840516 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78773444 |
| 136 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78285147 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78274914 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76797647 |
| 139 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73805060 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72562089 |
| 141 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.70582474 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69010547 |
| 143 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67775251 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66592570 |
| 145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.65613419 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.65110993 |
| 147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.63333539 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63330466 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61517945 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60633056 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60353887 |
| 152 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.60349171 |
| 153 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.60328705 |
| 154 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.60073462 |
| 155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59552587 |
| 156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59354625 |
| 157 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.58896466 |
| 158 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58833732 |
| 159 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.58496955 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58473872 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57802798 |
| 162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56757609 |
| 163 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.56385305 |
| 164 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56085144 |
| 165 | CJUN_26792858_Chip-Seq_BT549_Human | 0.55363926 |
| 166 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55264751 |
| 167 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55006047 |
| 168 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54830108 |
| 169 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54748794 |
| 170 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54234843 |
| 171 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52974929 |
| 172 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52044895 |
| 173 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.51445129 |
| 174 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51410838 |
| 175 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51290264 |
| 176 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50441911 |
| 177 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49384903 |
| 178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49383335 |
| 179 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49315643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.99236884 |
| 2 | MP0005360_urolithiasis | 6.83171584 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.58924056 |
| 4 | MP0003724_increased_susceptibility_to | 5.23807067 |
| 5 | MP0005365_abnormal_bile_salt | 5.19628491 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33453325 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.18106060 |
| 8 | MP0003436_decreased_susceptibility_to | 4.10962791 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.78590634 |
| 10 | MP0003303_peritoneal_inflammation | 3.59181914 |
| 11 | MP0003252_abnormal_bile_duct | 3.53379988 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.21713083 |
| 13 | MP0002419_abnormal_innate_immunity | 3.13408525 |
| 14 | MP0003195_calcinosis | 2.99197171 |
| 15 | MP0005332_abnormal_amino_acid | 2.90720802 |
| 16 | MP0009840_abnormal_foam_cell | 2.89640554 |
| 17 | MP0009785_altered_susceptibility_to | 2.77374533 |
| 18 | MP0005025_abnormal_response_to | 2.77091857 |
| 19 | MP0001800_abnormal_humoral_immune | 2.75571432 |
| 20 | MP0005671_abnormal_response_to | 2.74955401 |
| 21 | MP0000685_abnormal_immune_system | 2.73094884 |
| 22 | MP0006082_CNS_inflammation | 2.67491878 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.62361703 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.50077598 |
| 25 | MP0005387_immune_system_phenotype | 2.49607751 |
| 26 | MP0001790_abnormal_immune_system | 2.49607751 |
| 27 | MP0002723_abnormal_immune_serum | 2.46639046 |
| 28 | MP0005083_abnormal_biliary_tract | 2.42248818 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.40628956 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.38384411 |
| 31 | MP0002420_abnormal_adaptive_immunity | 2.37542762 |
| 32 | MP0001819_abnormal_immune_cell | 2.35031799 |
| 33 | MP0008260_abnormal_autophagy | 2.20533833 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 2.20154470 |
| 35 | MP0002132_abnormal_respiratory_system | 2.19651983 |
| 36 | MP0001533_abnormal_skeleton_physiology | 2.16593599 |
| 37 | MP0003172_abnormal_lysosome_physiology | 2.13423865 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 2.07854971 |
| 39 | MP0004130_abnormal_muscle_cell | 2.06821582 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 2.02803026 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.93200878 |
| 42 | MP0002405_respiratory_system_inflammati | 1.91900313 |
| 43 | MP0000609_abnormal_liver_physiology | 1.89239664 |
| 44 | MP0003828_pulmonary_edema | 1.87558464 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.85499743 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.82316746 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.81767559 |
| 48 | MP0002398_abnormal_bone_marrow | 1.77102233 |
| 49 | MP0000716_abnormal_immune_system | 1.76192629 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.75575257 |
| 51 | MP0004883_abnormal_blood_vessel | 1.73652194 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.71699918 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.68122762 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67652978 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.64452561 |
| 56 | MP0005670_abnormal_white_adipose | 1.64257566 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.60218208 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.58868314 |
| 59 | MP0003866_abnormal_defecation | 1.58573045 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.51728720 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.48830259 |
| 62 | MP0002722_abnormal_immune_system | 1.47346751 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.44938303 |
| 64 | MP0000858_altered_metastatic_potential | 1.42565485 |
| 65 | MP0004947_skin_inflammation | 1.41441379 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.40366547 |
| 67 | MP0005164_abnormal_response_to | 1.40110767 |
| 68 | MP0002429_abnormal_blood_cell | 1.39785607 |
| 69 | MP0009278_abnormal_bone_marrow | 1.39399934 |
| 70 | MP0004381_abnormal_hair_follicle | 1.37010673 |
| 71 | MP0003075_altered_response_to | 1.36287401 |
| 72 | MP0001764_abnormal_homeostasis | 1.32932501 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.31720588 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.31720588 |
| 75 | MP0003186_abnormal_redox_activity | 1.31414260 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 1.29048481 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.28211285 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.27356629 |
| 79 | MP0003868_abnormal_feces_composition | 1.22319735 |
| 80 | MP0009697_abnormal_copulation | 1.21309457 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.20172630 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.19806598 |
| 83 | MP0002971_abnormal_brown_adipose | 1.19600515 |
| 84 | MP0005310_abnormal_salivary_gland | 1.19015912 |
| 85 | MP0003646_muscle_fatigue | 1.17200531 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.16852198 |
| 87 | MP0001851_eye_inflammation | 1.16678875 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.15452415 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.15261365 |
| 90 | MP0010368_abnormal_lymphatic_system | 1.13421294 |
| 91 | MP0005451_abnormal_body_composition | 1.11281972 |
| 92 | MP0005330_cardiomyopathy | 1.06669101 |
| 93 | MP0003011_delayed_dark_adaptation | 1.05100020 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 1.02686160 |
| 95 | MP0000598_abnormal_liver_morphology | 1.02546361 |
| 96 | MP0005166_decreased_susceptibility_to | 1.00726098 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.99051551 |
| 98 | MP0002269_muscular_atrophy | 0.98529626 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.97887040 |
| 100 | MP0006054_spinal_hemorrhage | 0.97854193 |
| 101 | MP0004043_abnormal_pH_regulation | 0.97394779 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.95446310 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.95235152 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.95153495 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.93672964 |
| 106 | MP0000749_muscle_degeneration | 0.93253883 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.92472637 |
| 108 | MP0005535_abnormal_body_temperature | 0.91313761 |
| 109 | MP0000751_myopathy | 0.89951301 |
| 110 | MP0001853_heart_inflammation | 0.89216542 |
| 111 | MP0000343_altered_response_to | 0.85928804 |
| 112 | MP0004087_abnormal_muscle_fiber | 0.85603152 |
| 113 | MP0003448_altered_tumor_morphology | 0.85233520 |
| 114 | MP0008004_abnormal_stomach_pH | 0.85127112 |
| 115 | MP0005266_abnormal_metabolism | 0.83214261 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.82917644 |
| 117 | MP0001756_abnormal_urination | 0.82771060 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.80808920 |
| 119 | MP0005390_skeleton_phenotype | 0.80223557 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.80139372 |
| 121 | MP0009764_decreased_sensitivity_to | 0.79940952 |
| 122 | MP0005334_abnormal_fat_pad | 0.79343259 |
| 123 | MP0000604_amyloidosis | 0.78047469 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.76799485 |
| 125 | MP0009763_increased_sensitivity_to | 0.76583472 |
| 126 | MP0001663_abnormal_digestive_system | 0.75991869 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.75239708 |
| 128 | MP0003045_fibrosis | 0.74979757 |
| 129 | MP0005448_abnormal_energy_balance | 0.74968186 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.74527559 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.74452875 |
| 132 | MP0000249_abnormal_blood_vessel | 0.73361357 |
| 133 | MP0002006_tumorigenesis | 0.70448085 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.69919833 |
| 135 | MP0001986_abnormal_taste_sensitivity | 0.69608576 |
| 136 | MP0000747_muscle_weakness | 0.66962356 |
| 137 | MP0009115_abnormal_fat_cell | 0.66923270 |
| 138 | MP0004510_myositis | 0.66605803 |
| 139 | MP0002933_joint_inflammation | 0.66147987 |
| 140 | MP0001544_abnormal_cardiovascular_syste | 0.64658245 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.64658245 |
| 142 | MP0002972_abnormal_cardiac_muscle | 0.64361707 |
| 143 | MP0005620_abnormal_muscle_contractility | 0.64000995 |
| 144 | MP0005647_abnormal_sex_gland | 0.63641388 |
| 145 | MP0001958_emphysema | 0.63496485 |
| 146 | MP0003795_abnormal_bone_structure | 0.62380451 |
| 147 | MP0002822_catalepsy | 0.62266859 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.61639635 |
| 149 | MP0010630_abnormal_cardiac_muscle | 0.61543915 |
| 150 | MP0001661_extended_life_span | 0.61359668 |
| 151 | MP0008469_abnormal_protein_level | 0.60588577 |
| 152 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60125646 |
| 153 | MP0004484_altered_response_of | 0.59193627 |
| 154 | MP0002254_reproductive_system_inflammat | 0.59121361 |
| 155 | MP0006138_congestive_heart_failure | 0.58501957 |
| 156 | MP0009384_cardiac_valve_regurgitation | 0.58479269 |
| 157 | MP0005248_abnormal_Harderian_gland | 0.58155557 |
| 158 | MP0003300_gastrointestinal_ulcer | 0.57953924 |
| 159 | MP0003329_amyloid_beta_deposits | 0.57429483 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.57083594 |
| 161 | MP0000371_diluted_coat_color | 0.56913082 |
| 162 | MP0002168_other_aberrant_phenotype | 0.56589736 |
| 163 | MP0004808_abnormal_hematopoietic_stem | 0.56406335 |
| 164 | MP0002876_abnormal_thyroid_physiology | 0.56008441 |
| 165 | MP0002136_abnormal_kidney_physiology | 0.55908269 |
| 166 | MP0005275_abnormal_skin_tensile | 0.55779995 |
| 167 | MP0002970_abnormal_white_adipose | 0.54876816 |
| 168 | MP0005408_hypopigmentation | 0.52925572 |
| 169 | MP0009765_abnormal_xenobiotic_induced | 0.51383073 |
| 170 | MP0003690_abnormal_glial_cell | 0.51175000 |
| 171 | MP0003279_aneurysm | 0.50279236 |
| 172 | MP0003953_abnormal_hormone_level | 0.49623086 |
| 173 | MP0005165_increased_susceptibility_to | 0.47814726 |
| 174 | MP0008874_decreased_physiological_sensi | 0.46611567 |
| 175 | MP0009780_abnormal_chondrocyte_physiolo | 0.46353772 |
| 176 | MP0001765_abnormal_ion_homeostasis | 0.46277410 |
| 177 | MP0010234_abnormal_vibrissa_follicle | 0.46105707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.46521910 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.06079344 |
| 3 | Myositis (HP:0100614) | 6.05575046 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.99195079 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.85367712 |
| 6 | Orchitis (HP:0100796) | 5.80758456 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 5.77941141 |
| 8 | Deep venous thrombosis (HP:0002625) | 5.61572076 |
| 9 | Optic neuritis (HP:0100653) | 5.50020771 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 5.50020771 |
| 11 | Abnormality of macrophages (HP:0004311) | 5.34140289 |
| 12 | Xanthomatosis (HP:0000991) | 5.30146220 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.20798202 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.11299604 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.96224467 |
| 16 | Stomatitis (HP:0010280) | 4.92558522 |
| 17 | Hyperammonemia (HP:0001987) | 4.74131757 |
| 18 | Ketosis (HP:0001946) | 4.73354835 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.72652076 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 4.55072039 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.41181134 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 4.40454718 |
| 23 | Hyperglycinuria (HP:0003108) | 4.30333515 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 4.17152651 |
| 25 | Recurrent fungal infections (HP:0002841) | 4.16116170 |
| 26 | Ketoacidosis (HP:0001993) | 4.15705458 |
| 27 | Hypolipoproteinemia (HP:0010981) | 4.10647093 |
| 28 | Obstructive lung disease (HP:0006536) | 4.10407631 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 4.10407631 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09678681 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 4.09678681 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08485577 |
| 33 | Recurrent skin infections (HP:0001581) | 4.04937496 |
| 34 | Hyperglycinemia (HP:0002154) | 3.97971186 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.95547421 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.91658378 |
| 37 | Complement deficiency (HP:0004431) | 3.86267050 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84516447 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.84440557 |
| 40 | Meningitis (HP:0001287) | 3.78877681 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.78468166 |
| 42 | Gingival bleeding (HP:0000225) | 3.78461985 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.73466601 |
| 44 | Encephalitis (HP:0002383) | 3.69335043 |
| 45 | Epidermoid cyst (HP:0200040) | 3.68175912 |
| 46 | Keratoconjunctivitis (HP:0001096) | 3.67079036 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.65103919 |
| 48 | Peritonitis (HP:0002586) | 3.64494968 |
| 49 | Spontaneous hematomas (HP:0007420) | 3.64075980 |
| 50 | Prolonged bleeding time (HP:0003010) | 3.59481646 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 3.54316690 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.54316690 |
| 53 | Gingivitis (HP:0000230) | 3.51703699 |
| 54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.48095359 |
| 55 | Urticaria (HP:0001025) | 3.47629805 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45963660 |
| 57 | Vasculitis (HP:0002633) | 3.43288168 |
| 58 | Episodic fever (HP:0001954) | 3.42334010 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 3.35671366 |
| 60 | Amyloidosis (HP:0011034) | 3.29223402 |
| 61 | Chest pain (HP:0100749) | 3.24288280 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 3.24185819 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.24185819 |
| 64 | Fat malabsorption (HP:0002630) | 3.21117603 |
| 65 | Hypochromic anemia (HP:0001931) | 3.19413299 |
| 66 | T lymphocytopenia (HP:0005403) | 3.18072782 |
| 67 | Epistaxis (HP:0000421) | 3.14336395 |
| 68 | Arterial thrombosis (HP:0004420) | 3.13487375 |
| 69 | Hemoptysis (HP:0002105) | 3.11827677 |
| 70 | Abnormality of T cell number (HP:0011839) | 3.11714560 |
| 71 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11379319 |
| 72 | Pulmonary infiltrates (HP:0002113) | 3.10694571 |
| 73 | Abnormality of methionine metabolism (HP:0010901) | 3.09686276 |
| 74 | Metabolic acidosis (HP:0001942) | 3.08086617 |
| 75 | Joint hemorrhage (HP:0005261) | 3.05279882 |
| 76 | Pulmonary embolism (HP:0002204) | 3.03176566 |
| 77 | Hyperbilirubinemia (HP:0002904) | 3.01306304 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 3.00193209 |
| 79 | Increased IgE level (HP:0003212) | 2.99559887 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.98405512 |
| 81 | Gout (HP:0001997) | 2.94925648 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.92776883 |
| 83 | Anorexia (HP:0002039) | 2.91475737 |
| 84 | Abnormality of the intrinsic pathway (HP:0010989) | 2.90278092 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.89542980 |
| 86 | Cerebral edema (HP:0002181) | 2.87633374 |
| 87 | Myoglobinuria (HP:0002913) | 2.85519649 |
| 88 | Leukocytosis (HP:0001974) | 2.83698395 |
| 89 | Cellulitis (HP:0100658) | 2.83333815 |
| 90 | Lethargy (HP:0001254) | 2.82580297 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81993825 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.81493792 |
| 93 | Abnormality of complement system (HP:0005339) | 2.70312833 |
| 94 | Late onset (HP:0003584) | 2.68733469 |
| 95 | Skin nodule (HP:0200036) | 2.68685561 |
| 96 | Abnormality of T cells (HP:0002843) | 2.60006378 |
| 97 | Gangrene (HP:0100758) | 2.59330742 |
| 98 | Abnormality of the peritoneum (HP:0002585) | 2.58444912 |
| 99 | Recurrent viral infections (HP:0004429) | 2.55213194 |
| 100 | Myocardial infarction (HP:0001658) | 2.53698801 |
| 101 | Pustule (HP:0200039) | 2.52728476 |
| 102 | Vascular calcification (HP:0004934) | 2.52572211 |
| 103 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51944530 |
| 104 | Petechiae (HP:0000967) | 2.49230368 |
| 105 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49170450 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.46153765 |
| 107 | Purpura (HP:0000979) | 2.45045966 |
| 108 | Vomiting (HP:0002013) | 2.44659079 |
| 109 | Inflammation of the large intestine (HP:0002037) | 2.43799864 |
| 110 | Hydroxyprolinuria (HP:0003080) | 2.43411427 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 2.43411427 |
| 112 | Microcytic anemia (HP:0001935) | 2.40387627 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.39885422 |
| 114 | Osteomyelitis (HP:0002754) | 2.39607787 |
| 115 | Cholelithiasis (HP:0001081) | 2.39036610 |
| 116 | Increased IgM level (HP:0003496) | 2.36300190 |
| 117 | Granulocytopenia (HP:0001913) | 2.35881669 |
| 118 | Hepatocellular carcinoma (HP:0001402) | 2.34479147 |
| 119 | Gastrointestinal inflammation (HP:0004386) | 2.34144972 |
| 120 | Abnormal gallbladder morphology (HP:0012437) | 2.34039822 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.29479240 |
| 122 | Glomerulopathy (HP:0100820) | 2.29055555 |
| 123 | Proximal tubulopathy (HP:0000114) | 2.26837032 |
| 124 | Right ventricular cardiomyopathy (HP:0011663) | 2.26560793 |
| 125 | Abnormal platelet volume (HP:0011876) | 2.25631135 |
| 126 | Esophageal varix (HP:0002040) | 2.25282824 |
| 127 | Increased serum ferritin (HP:0003281) | 2.24987726 |
| 128 | Acute hepatic failure (HP:0006554) | 2.22888157 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 2.22098848 |
| 130 | Panhypogammaglobulinemia (HP:0003139) | 2.22033561 |
| 131 | Steatorrhea (HP:0002570) | 2.21457104 |
| 132 | Polycythemia (HP:0001901) | 2.20786982 |
| 133 | Thrombophlebitis (HP:0004418) | 2.20670563 |
| 134 | Rhabdomyolysis (HP:0003201) | 2.20625754 |
| 135 | Neonatal onset (HP:0003623) | 2.19572467 |
| 136 | Abnormality of T cell physiology (HP:0011840) | 2.17230825 |
| 137 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16504273 |
| 138 | Hyperuricemia (HP:0002149) | 2.16423131 |
| 139 | Increased purine levels (HP:0004368) | 2.16423131 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 2.16104808 |
| 141 | Keratitis (HP:0000491) | 2.15885726 |
| 142 | Acne (HP:0001061) | 2.15566220 |
| 143 | Abnormal gallbladder physiology (HP:0012438) | 2.14271136 |
| 144 | Cholecystitis (HP:0001082) | 2.14271136 |
| 145 | Nausea (HP:0002018) | 2.13626397 |
| 146 | Abnormality of the endocardium (HP:0004306) | 2.12379605 |
| 147 | Sepsis (HP:0100806) | 2.12014996 |
| 148 | Hepatic necrosis (HP:0002605) | 2.11633966 |
| 149 | Vertigo (HP:0002321) | 2.11490349 |
| 150 | Pancreatitis (HP:0001733) | 2.11197514 |
| 151 | Increased cerebral lipofuscin (HP:0011813) | 2.09117803 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 2.08223688 |
| 153 | Malnutrition (HP:0004395) | 2.07454287 |
| 154 | Eosinophilia (HP:0001880) | 2.04288964 |
| 155 | Palpitations (HP:0001962) | 2.03932442 |
| 156 | Spastic diplegia (HP:0001264) | 2.03166249 |
| 157 | Abnormality of the Achilles tendon (HP:0005109) | 2.02260244 |
| 158 | Polyneuropathy (HP:0001271) | 2.01272607 |
| 159 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00326929 |
| 160 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00326929 |
| 161 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00326929 |
| 162 | Irritability (HP:0000737) | 1.97354263 |
| 163 | Skin ulcer (HP:0200042) | 1.96973061 |
| 164 | Glycosuria (HP:0003076) | 1.96762664 |
| 165 | Abnormality of urine glucose concentration (HP:0011016) | 1.96762664 |
| 166 | Menorrhagia (HP:0000132) | 1.96737509 |
| 167 | Hypergammaglobulinemia (HP:0010702) | 1.95821178 |
| 168 | Viral hepatitis (HP:0006562) | 1.95160094 |
| 169 | Abnormality of the pericardium (HP:0001697) | 1.94979694 |
| 170 | Exercise-induced muscle cramps (HP:0003710) | 1.94406482 |
| 171 | Subacute progressive viral hepatitis (HP:0006572) | 1.93927401 |
| 172 | Spontaneous abortion (HP:0005268) | 1.93625146 |
| 173 | Hemorrhage of the eye (HP:0011885) | 1.91742487 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91730292 |
| 175 | Cheilitis (HP:0100825) | 1.91213836 |
| 176 | Skin rash (HP:0000988) | 1.89905931 |
| 177 | Acute encephalopathy (HP:0006846) | 1.89673815 |
| 178 | Exercise-induced myalgia (HP:0003738) | 1.89409502 |
| 179 | Lymphopenia (HP:0001888) | 1.88256634 |
| 180 | Loss of speech (HP:0002371) | 1.88239917 |
| 181 | Hepatosplenomegaly (HP:0001433) | 1.86422834 |
| 182 | Mitral stenosis (HP:0001718) | 1.84974190 |
| 183 | Joint swelling (HP:0001386) | 1.84828598 |
| 184 | Abnormality of the gallbladder (HP:0005264) | 1.83529387 |
| 185 | Acanthocytosis (HP:0001927) | 1.81437086 |
| 186 | Slow saccadic eye movements (HP:0000514) | 1.81177312 |
| 187 | Opisthotonus (HP:0002179) | 1.81088028 |
| 188 | Hyperglycemia (HP:0003074) | 1.79026026 |
| 189 | Hypochromic microcytic anemia (HP:0004840) | 1.78942690 |
| 190 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78388940 |
| 191 | Rickets (HP:0002748) | 1.77849018 |
| 192 | Axonal loss (HP:0003447) | 1.75725553 |
| 193 | Enlarged kidneys (HP:0000105) | 1.75684554 |
| 194 | Renal cortical cysts (HP:0000803) | 1.75031635 |
| 195 | Increased muscle lipid content (HP:0009058) | 1.73349674 |
| 196 | Systemic lupus erythematosus (HP:0002725) | 1.73076627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.45560342 |
| 2 | RIPK4 | 4.92784373 |
| 3 | TRIB3 | 4.30461190 |
| 4 | ERN1 | 3.46575752 |
| 5 | SIK1 | 3.43173852 |
| 6 | BLK | 3.28076680 |
| 7 | MAP4K1 | 3.18482654 |
| 8 | IRAK4 | 3.12589274 |
| 9 | TYK2 | 3.01420865 |
| 10 | CSK | 2.90241838 |
| 11 | PKN2 | 2.89257760 |
| 12 | FGFR4 | 2.85865038 |
| 13 | FES | 2.70444720 |
| 14 | GRK6 | 2.31295737 |
| 15 | LMTK2 | 2.23831891 |
| 16 | PDK3 | 2.20227169 |
| 17 | PDK4 | 2.20227169 |
| 18 | ZAP70 | 2.12815571 |
| 19 | TNK2 | 2.08055752 |
| 20 | MAP3K3 | 1.99899347 |
| 21 | JAK3 | 1.92929504 |
| 22 | FGR | 1.91560910 |
| 23 | TTN | 1.91210077 |
| 24 | TXK | 1.88787397 |
| 25 | BTK | 1.84078658 |
| 26 | HCK | 1.80041093 |
| 27 | SYK | 1.76843960 |
| 28 | NEK1 | 1.72851126 |
| 29 | MST1R | 1.65536389 |
| 30 | PDGFRA | 1.61288038 |
| 31 | PRPF4B | 1.52826041 |
| 32 | MAP3K14 | 1.51572935 |
| 33 | PIK3CG | 1.50867250 |
| 34 | LYN | 1.44906156 |
| 35 | TIE1 | 1.42716357 |
| 36 | MAP3K7 | 1.42131139 |
| 37 | INSRR | 1.40565838 |
| 38 | YES1 | 1.37486642 |
| 39 | IKBKE | 1.35887750 |
| 40 | MYLK | 1.34485496 |
| 41 | PTK6 | 1.33725975 |
| 42 | CSF1R | 1.32003688 |
| 43 | WNK4 | 1.31615204 |
| 44 | MAPK11 | 1.29948019 |
| 45 | RIPK1 | 1.28918019 |
| 46 | MATK | 1.28914216 |
| 47 | FLT3 | 1.27088627 |
| 48 | LATS1 | 1.24078047 |
| 49 | BMPR2 | 1.22501645 |
| 50 | TGFBR2 | 1.21722864 |
| 51 | LCK | 1.20009818 |
| 52 | PHKG1 | 1.19606121 |
| 53 | PHKG2 | 1.19606121 |
| 54 | MAP2K4 | 1.17238531 |
| 55 | MAP3K2 | 1.17048184 |
| 56 | ITK | 1.16178879 |
| 57 | NEK9 | 1.15528568 |
| 58 | PIK3CA | 1.15288808 |
| 59 | IRAK1 | 1.15213590 |
| 60 | TEC | 1.14818987 |
| 61 | ERBB4 | 1.14198691 |
| 62 | KIT | 1.13359078 |
| 63 | SIK3 | 1.11149655 |
| 64 | FGFR2 | 1.10891178 |
| 65 | OBSCN | 1.10488409 |
| 66 | PDK2 | 1.03573886 |
| 67 | PINK1 | 1.02924545 |
| 68 | FRK | 1.02469489 |
| 69 | KDR | 1.01222284 |
| 70 | CAMK1D | 0.99463786 |
| 71 | PRKAA2 | 0.98942244 |
| 72 | PAK3 | 0.97476105 |
| 73 | MARK3 | 0.96581683 |
| 74 | EPHB1 | 0.95002635 |
| 75 | MAP3K6 | 0.93244631 |
| 76 | PTK2B | 0.91066301 |
| 77 | DAPK2 | 0.90065204 |
| 78 | STK10 | 0.89054531 |
| 79 | IRAK2 | 0.87281491 |
| 80 | PTK2 | 0.87034325 |
| 81 | MAP2K3 | 0.85650105 |
| 82 | MET | 0.82674121 |
| 83 | LRRK2 | 0.82117922 |
| 84 | MARK2 | 0.80867036 |
| 85 | DYRK1B | 0.79968631 |
| 86 | CDK6 | 0.79500154 |
| 87 | MAP2K1 | 0.77155886 |
| 88 | MAPK12 | 0.77146928 |
| 89 | IKBKB | 0.76405797 |
| 90 | MAP3K11 | 0.75791529 |
| 91 | CDK19 | 0.75745188 |
| 92 | PRKAA1 | 0.75496363 |
| 93 | ABL2 | 0.74256002 |
| 94 | PRKD2 | 0.73525004 |
| 95 | DDR2 | 0.69546283 |
| 96 | RET | 0.68013879 |
| 97 | BMX | 0.66005009 |
| 98 | FYN | 0.65917320 |
| 99 | CAMK2G | 0.65299193 |
| 100 | PRKD1 | 0.64750258 |
| 101 | SGK3 | 0.63579946 |
| 102 | PRKACG | 0.62603937 |
| 103 | TBK1 | 0.62404389 |
| 104 | RAF1 | 0.62049734 |
| 105 | FER | 0.59438437 |
| 106 | GSK3A | 0.59236463 |
| 107 | FGFR1 | 0.57672285 |
| 108 | DAPK3 | 0.56975140 |
| 109 | MAP3K1 | 0.56760849 |
| 110 | PDPK1 | 0.56648534 |
| 111 | WNK1 | 0.56398434 |
| 112 | TAOK1 | 0.56264789 |
| 113 | STK38 | 0.55817312 |
| 114 | PRKCQ | 0.55801779 |
| 115 | NME2 | 0.54969813 |
| 116 | TAOK3 | 0.54939764 |
| 117 | JAK2 | 0.54861345 |
| 118 | PRKG2 | 0.54702703 |
| 119 | DMPK | 0.53975324 |
| 120 | STK38L | 0.52148556 |
| 121 | KSR1 | 0.50733072 |
| 122 | STK11 | 0.50335614 |
| 123 | KSR2 | 0.50128243 |
| 124 | MAPK15 | 0.50125035 |
| 125 | TESK2 | 0.49182711 |
| 126 | FGFR3 | 0.48663397 |
| 127 | PAK2 | 0.48504258 |
| 128 | CAMKK2 | 0.47969099 |
| 129 | ICK | 0.47770031 |
| 130 | CAMK4 | 0.47735946 |
| 131 | CAMKK1 | 0.47540254 |
| 132 | EPHA3 | 0.46507204 |
| 133 | GRK7 | 0.46038103 |
| 134 | SIK2 | 0.45945409 |
| 135 | MTOR | 0.44242094 |
| 136 | MAP3K13 | 0.43530667 |
| 137 | NLK | 0.43246803 |
| 138 | MAPKAPK2 | 0.42636077 |
| 139 | SGK2 | 0.42394356 |
| 140 | MAP3K5 | 0.42299973 |
| 141 | PIM2 | 0.41965227 |
| 142 | PIM1 | 0.41829643 |
| 143 | MAPK4 | 0.41749491 |
| 144 | MAPK7 | 0.40616726 |
| 145 | MAP2K6 | 0.40519881 |
| 146 | SGK223 | 0.39809424 |
| 147 | SGK494 | 0.39809424 |
| 148 | CDC42BPA | 0.39687704 |
| 149 | LATS2 | 0.39383185 |
| 150 | PDK1 | 0.39365870 |
| 151 | TAOK2 | 0.38155420 |
| 152 | HIPK2 | 0.37827790 |
| 153 | ILK | 0.36191169 |
| 154 | CAMK2D | 0.36014952 |
| 155 | AKT2 | 0.34689731 |
| 156 | CAMK1G | 0.34683147 |
| 157 | PRKCZ | 0.34440694 |
| 158 | WNK3 | 0.33747325 |
| 159 | ACVR1B | 0.33430679 |
| 160 | JAK1 | 0.33403924 |
| 161 | MAP3K12 | 0.32666844 |
| 162 | SMG1 | 0.32620825 |
| 163 | PRKCD | 0.27626298 |
| 164 | RPS6KC1 | 0.27358405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74802055 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53450588 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.32426530 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.05424425 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.99454155 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.99148505 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99143199 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.88094965 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81772964 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.78092587 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75889338 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59232766 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53023102 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.51831478 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.44415865 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.40412262 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36903082 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.35922926 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33466365 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27935521 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.27162918 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14540290 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.13152554 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12837153 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09187825 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07672399 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05685464 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 2.03788449 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02166513 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99009396 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95613298 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90928866 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.89931230 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86018825 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84481741 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82306702 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77679555 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76473234 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75541095 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.75028146 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73440677 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73333194 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71538078 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69555760 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68069168 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66959746 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.64451682 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59703326 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57952018 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57672066 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.54719083 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53851591 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53674656 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53520718 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51936512 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51341755 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.50570430 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49417504 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49209052 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48549638 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 1.47420826 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46852873 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42314309 |
| 64 | Asthma_Homo sapiens_hsa05310 | 1.41478539 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39803819 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37575868 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 1.37386827 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37137933 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36305940 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36065717 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35341419 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33842226 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31336533 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30963278 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29689691 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26910644 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23918534 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23459946 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23127236 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22272463 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22206269 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21911873 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20485483 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 1.18740395 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17482321 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17110243 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11916469 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09516528 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 1.05321259 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03422858 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02673697 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01388697 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01180243 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00765861 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.97348707 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95495857 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.94629758 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.94112073 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.93643443 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92330722 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92079727 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91218946 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90846390 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89343165 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.89274611 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88599030 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88159094 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86916814 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.83665079 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82441624 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80011511 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78958596 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77977032 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.76749139 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.76079813 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74452985 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73851918 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73599319 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70601452 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70355451 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70242275 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69320761 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69320561 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67916888 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67715045 |
| 126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65398766 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64745152 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63039587 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61917198 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61144062 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.60021502 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58556493 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57110902 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54260044 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52815256 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51958770 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51942316 |
| 138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49715522 |
| 139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49365443 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47746043 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47469077 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46978898 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46487348 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45370567 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45114186 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44493852 |
| 147 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43986053 |
| 148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43503427 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.43363150 |
| 150 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39026168 |
| 151 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38828910 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35813433 |
| 153 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35769118 |
| 154 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33820222 |
| 155 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33247785 |
| 156 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32700544 |
| 157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31980857 |
| 158 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31098937 |
| 159 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30776063 |
| 160 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29983859 |
| 161 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29686567 |
| 162 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27937723 |
| 163 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27911481 |
| 164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26230025 |
| 165 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25776077 |
| 166 | Prion diseases_Homo sapiens_hsa05020 | 0.19447860 |
| 167 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17085640 |
| 168 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16352993 |
| 169 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.12442269 |
| 170 | Parkinsons disease_Homo sapiens_hsa05012 | 0.09476833 |
| 171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08797707 |
| 172 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.06654714 |
| 173 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.05749050 |
| 174 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04488578 |
| 175 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03126384 |
| 176 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02741911 |
| 177 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.02544922 |
| 178 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02250307 |
| 179 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.02029168 |
| 180 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0910681 |
| 181 | Mineral absorption_Homo sapiens_hsa04978 | -0.0709559 |
| 182 | Bladder cancer_Homo sapiens_hsa05219 | -0.0653114 |
| 183 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0486371 |
| 184 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0456774 |
| 185 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0418824 |
| 186 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0406423 |
| 187 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0377810 |
| 188 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0215539 |
| 189 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0191396 |
| 190 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0132016 |

